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Epidermodysplasia verruciformis (EV) is characterized
by an abnormal genetic susceptibility to a group of related
human papillomavirus (HPV) genotypes, including the
oncogenic HPV5 and HPV8. The mode of transmission
of these viruses remains unknown. In view of the rare
incidence of EV, we had a unique opportunity to perform
a virologic study of the amniotic fluid and placenta from
an EV patient infected with HPV5, HPV8, several other
EV HPV, and HPV3. The child was born by cesarean
section and the amniotic fluid specimen was taken prior
to rupture of membranes. Analysis of the amniotic fluid
and placenta specimens by a nested polymerase chain
reaction method, using degenerate EV HPV primers or
type-specific HPV primers, disclosed the presence of the
Epidermodysplasia verruciformis (EV) is a rare life-long skindisease, characterized by an abnormal genetic susceptibilityto infection by a group of related human papillomaviruses(EV HPV) (Majewski and Jablonska, 1995). Some of theseviruses, mainly HPV5 and less frequently HPV8, HPV14,
HPV17, HPV20, and HPV47, are associated with the skin carcinomas
developing in patients (Orth, 1987). EV is a rare experiment of nature
that raises numerous questions, among which are the bases of the host
restriction characterizing EV HPV and the mode of transmission of
these viruses. The reservoir of EV HPV had long remained unknown.
Recently, the use of highly sensitive nested polymerase chain reaction
(PCR) methods disclosed the high prevalence of DNA sequences of
most EV HPV and related genotypes in plucked hairs (Boxman et al,
1997) and in precancerous lesions and invasive carcinomas of the skin
(Berkhout et al, 1995; de Villiers et al, 1997; Pfister and ter Schegget,
1997). Moreover, HPV5 was detected in a great majority of patients
suffering from psoriasis, and anti-HPV5 antibodies were found in a
significant proportion of such patients (Favre et al, 1998). These
observations indicate that EV HPV are widespread but their mode of
transmission remains unkown.
Infection with EV HPV occurs early in the life of patients, with the
first lesions usually developing between 4 and 7 y of age (Majewski
and Jablonska, 1995). Several cases of onset of EV during the first year
of life have been reported (Prystowsky et al, 1976; Rueda and
Rodriguez, 1976; Lutzner et al, 1984). It is worth mentioning that in
the first case of EV described (Lewandowsky and Lutz, 1922), the
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variants of EV HPV5, HPV8, HPV24, and HPV36, and
of HPV3 detected in the skin lesions of the patient.
HPV5, HPV8, HPV24, and HPV3 were also detected
in the placenta. No viral sequences were detected in
peripheral blood mononuclear cells collected 2 y and
6 mo before cesarean section, rendering an hematogenous
transmission unlikely. The same HPV variants were also
detected in cervical scrapes taken from the patient, which
may suggest an ascending infection of the placenta. This
first report of the detection of EV HPV in amniotic fluid,
placenta, and cervical scrapes from an EV patient renders
vertical transmission of EV HPV likely. Key words: amniotic
fluid/mucous membranes/nested PCR/oncogenic EV HPV/
placenta. J Invest Dermatol 111:333–336, 1998
patient’s mother claimed that the skin lesions were present at birth.
This may suggest vertical transmission of EV HPV.
Several reports have stressed the possibility of a perinatal or neonatal
transmission of genital HPV, in particular the oncogenic HPV16 and
HPV18. Such transmission could occur at birth through an infected
birth canal (Sedlacek et al, 1989; Cason et al, 1995; Puranen et al,
1996) and it is likely to account for anogenital warts or juvenile
respiratory papillomatosis occuring in infancy or early childhood
(Mounts and Shah, 1984; Cohen et al, 1990; Obalek et al, 1997). A
possible transmission in utero has been strongly suggested by reports of
children born with anogenital condylomata (Tang et al, 1978; Rogo
and Nyansera, 1989; Cohen et al, 1990), as well as by the detection
of genital oncogenic genotypes in amniotic fluid (Sedlacek et al, 1989;
Armbruster-Moraes et al, 1994) and cord blood specimens from
neonates (Tseng et al, 1992) or in nasal aspirates and buccal or genital
swabs taken from children born by cesarean section (Puranen et al,
1997; Tseng et al, 1998).
In view of the rare incidence of EV, we had a unique opportunity
to perform a virologic study of the amniotic fluid and placenta from
an EV patient infected by several EV HPV, including the oncogenic
HPV5 and HPV8. The results of our study support a possible vertical
transmission of EV HPV.
MATERIALS AND METHODS
Patient The patient, in our care since early childhood (Jablonska et al, 1979),
has a familial form of EV with typical cutaneous lesions which started to appear
at the age of 7 y. Several precancerous changes and carcinomas in situ have
been steadily developing on the face and neck since the age of 23 y and were
removed by surgery or laser treatment. Extensive virologic studies have been
performed previously on this patient, demonstrating infection with five EV
HPV genotypes (HPV5, HPV8, HPV19, HPV24, and HPV36) and with HPV3.
Cloning and characterization of the genome of the isolates of HPV3 and HPV8
predominantly found in flat wart-like lesions and pityriasis versicolor-like lesions,
respectively, and identification of the isolate of HPV5 (E6 variant of HPV5a)
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Table I. Detection and identification of HPV DNA sequences
by nested PCR and sequencinga
Genotypes identified using primers specific for
Specimensb
(month/year) EV HPV HPV5, HPV8, HPV24, HPV36, or
HPV3
pv-like (4/77) 5 1 8c 5, 8,c 24, 36, 3
fw-like (6/95) 19c 5, 8,c 24, 36, 3c
amniotic fluid (1/97) 36 5, 8, 24, 36, 3
placenta 1 (1/97) – d 8, 24, 3
placenta 2 (1/97) – 5, 24
placenta 3 (1/97) – 5, 8
PBMC (2/95) – –
PBMC (6/96) – –
cervical scrapes (12/97) 8c 5, 8,c 24, 36, 3
oral scrapes (10/97) 8 1 X7c 5, 8,c 24, 36, 3
aNested PCR using primers specific for EV HPV (Berkhout et al, 1995), HPV3, HPV5,
HPV8, HPV24, or HPV36, and direct sequencing of PCR products were performed as
described in Materials and Methods.
bpv-like, pityriasis versicolor-like lesions; fw-like, flat wart-like lesions; PBMC, peripheral
blood mononuclear cells.
cAmplification products were detected after the first round of PCR by ethidium bromide
staining of the gel.
d—, no amplification products detected after the second round of PCR by ethidium
bromide staining.
predominantly detected in premalignant lesions, have been reported previously
(Kremsdorf et al, 1983; Kawase et al, 1996). The patient had previous therapy
for infertility, which proved to be unsuccessful. At the age of 39 y she became
pregnant without any medical intervention and delivered on time a healthy
male baby. The delivery was performed by cesarean section and was uneventful.
Clinical samples Informed consent was obtained from the patient. Specimens
and dates of collection are listed in Table I. Amniotic fluid (20 ml) was
collected by syringe directly from the amniotic cavity prior to rupture of fetal
membranes and three fragments of placenta were taken for virologic studies.
Cell scrapes were collected in minimum essential medium of Eagle from the
uterine cervix and the oral mucosa of the mother in the year following delivery.
Blood samples (5 ml) were drawn from the mother prior and during pregnancy.
DNA preparations Total cell DNA was extracted from exfoliated amniotic,
cervical, and oral cells, from peripheral blood mononuclear cells purified from
the blood samples, and from placenta fragments as previously described (Kawase
et al, 1996). Two DNA preparations from scrapings of pityriasis versicolor-like
lesions of the trunk and from scrapings of flat wart-like lesions of the dorsa of
the hands obtained during the previous virologic follow-up of the patient were
included in this study.
PCR analysis The adequacy of DNA preparations was tested by PCR using
β globin primers (Greer et al, 1991). EV-associated HPV were searched for by
a nested PCR method with two sets of degenerate primers (CP65/CP70 and
CP66/CP69) located in the L1 open reading frame as described (Berkhout et al,
1995). To detect specific HPV types, a nested PCR was performed using
primers located in the L1 open reading frame of HPV3 (3L1), HPV5 (5L1),
HPV8 (8L1), HPV24 (24L1), and HPV36 (36L1). 5L1 and 36L1 primers have
been described previously (Favre et al, 1998). The nucleotide (nt) positions of
the two pairs of primers (1 and 2; 3 and 4) are for 3L1, nt 5751–5770 and
6685–6704; nt 5811–5830 and 6142–6161, for 8L1, nt 5945–5964 and 6559–
6578; nt 6059–6078 and 6494–6513, and for 24L1, nt 5797–5816 and 6469–
6488; nt 5874–5893 and 6390–6409 (Myers et al, 1995). PCR reaction mixtures
contained 0.5–1 µg total cellular DNA, 50 mM KCl, 10 mM Tris-HCl
(pH 8.3), 0.1 mM each deoxynucleotide triphosphate, 2.5 mM MgCl2, 100 ng
of each primer of the first pair (primers 1 and 2), and 2 units of Thermus
aquaticus DNA polymerase (Perkin-Elmer, Emeryville, CA). Mixtures were
incubated for 5 min at 95°C and 35 cycles of amplification (1 min at 95°C,
1 min at 55°C, and 2 min at 72°C) were performed with a PCR processor
(Perkin-Elmer Cetus 9600). Subsequently, 5 µl of the first PCR were amplified
with the second set of primers (primers 3 and 4). A reagent control without
template DNA was included every eight PCR reactions. Cloned HPV3, HPV5,
HPV8, HPV24, and HPV36 DNA (1 ng) were used as positive controls. PCR
products (10 µl) obtained after the first and second rounds of amplification
were analyzed by agarose gel electrophoresis and stained with ethidium bromide
to visualize amplimers. The size of the fragments varied between 374 and 389
base pairs for CP66/CP69 primers and between 351 (HPV3) and 536 (HPV24)
for L1 specific primers 3 and 4. Because of the high sensitivity of the nested
PCR approach, extreme care was taken to avoid cross-contamination between
samples and carry-over of amplified sequences as recommended by Kwok
(1990). In particular, pre- and post-PCR amplification steps were performed
in separate rooms.
DNA sequence analysis Direct sequencing of amplification products was
performed using the ABI Prism Big dye terminator cycle sequencing reaction
kit with the AmpliTaq FS DNA polymerase (Perkin-Elmer, Les Ullis, France)
as recommended by the supplier. Sequence products were analyzed with an
ABI Prism 377 DNA sequencer (Perkin-Elmer). Sequences were compared
with the available sequences in the EMBL/GenBank Databank using the
FASTA program.
Nucleotide accession numbers Sequences have been deposited at EMBL
data base under accession numbers AJ223856 for the HPV3 variant, AJ223857
for the HPV8 variant, AJ223858 for the HPV24 variant, and AJ224118 for the
HPV36 variant.
RESULTS
Detection of EV HPV in amniotic fluid and placenta Virologic
follow-up of the EV patient has been performed since 1976, by
analyzing specimens of skin lesions using the Southern blot hybridization
technique. The patient was found infected by at least five EV HPV
genotypes, HPV19, HPV24, HPV36, and the oncogenic HPV5 and
HPV8, as well as by HPV3 usually associated with flat warts (patient
E in Orth, 1987). These genotypes were searched for in an amniotic
fluid sample taken prior to rupture of membranes and in placenta
fragments by using a nested PCR approach with degenerate primers
designed for the detection of EV HPV and related genotypes (Berkhout
et al, 1995) or primers specific for HPV3, HPV5, HPV8, HPV24, and
HPV36 (Table I, Fig 1). Genotypes were identified by direct sequen-
cing of the amplified L1 fragments obtained after the second round of
PCR. The expected six HPV genotypes were detected by this approach
in DNA preparations from pooled scrapings of the patient’s EV lesions
taken at an 18 y interval. HPV types 3, 5, 8, 24, and 36 were detected
in the amniotic fluid specimen but, in contrast to skin lesions,
amplification products were only observed after the second round of
PCR using degenerate or type-specific primers; this indicates the
presence of small amounts of viral DNA sequences. Two or three of
these genotypes, including HPV5 and/or HPV8, were detected after
the second round of PCR in each fragment of placenta using type-
specific primers only. In contrast, no HPV sequence was detected in
peripheral blood mononuclear cells collected 2 y and 6 mo (during
pregnancy) before cesarean section (Table I, Fig 1). The same variant
of each of the genotypes was identified in specimens: the E6 variant
of HPV5a differing from the prototypical HPV5 by six nucleotide
substitutions (Kawase et al, 1996), and variants of HPV3, HPV8,
HPV24, and HPV36 differing from the prototypes (Myers et al, 1995)
by two (A5934→G, C6101→G), two (A6125→G, G6379→A), one
(A6288→G), and four (A6148→G, G6325→A, G6421→A,
C6517→T) nucleotide substitutions, respectively (for accession
numbers, see Materials and Methods).
Detection of EV HPV in scrapes of the cervical and oral mucous
membranes To search for a possible infection of genital mucosa by
EV HPV, which could account for ascending infection of placenta,
cervical scrapes were taken from the mother 11 mo after the cesarean
section. HPV types 3, 5, 8, 24, and 36 were detected in the specimen
(Fig 1). The same genotypes, as well as RTRX7, an HPV related to
EV HPV12 (Bens et al, 1998), were detected in oral scrapes taken
from the mother 9 mo after delivery. HPV8 sequences were in
sufficient amounts to be detected in cervical and oral scrapes after
the first round of PCR with both degenerate and type-specific
primers (Table I).
DISCUSSION
This is the first report of the detection of EV HPV genotypes, including
the oncogenic HPV5 and HPV8, in the amniotic fluid and placenta
obtained from an EV patient. The EV HPV5, HPV8, HPV24, and
HPV36 and HPV3 isolates detected were the same variants found in
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Figure 1. Detection of EV HPV DNA sequences. DNA from various
specimens taken from the mother was analyzed by nested PCR using the
CP65/CP70 and CP66/CP69 primers aimed at the detection of EV HPV
(Berkhout et al, 1995) and primers specific for HPV types 5, 8, 24, 36, and 3.
Positive controls were cloned HPV DNA as indicated and cloned HPV5 DNA
for EV HPV detected with CP65/CP70 and CP66/CP69 primers. DNA was
omitted in the PCR reaction mixture as a negative control. Amplification
products obtained after the first round (primers CP65/CP70) and the second
round (primers CP66/CP69 or specific primers 3/4) of PCR were analyzed by
agarose gel electrophoresis and detected after ethidium bromide staining of the
gels. The adequacy of cellular DNA preparations was demonstrated by PCR
amplification of β-globin sequences (Greer et al, 1991).
skin lesions. HPV genotypes were detected only after the second round
of a nested PCR method, which indicates a low copy number of viral
DNA. Moreover, HPV sequences were detected with both degenerate
and type-specific primers in the amniotic fluid but only with type-
specific primers in the placenta specimens. This may relate to a lesser
abundance of HPV DNA in placenta DNA preparations and to the
lower sensitivity of the nested PCR approach using degenerate primers.
Each set of degenerate primers contains a mixture of 16 (CP65, CP66,
and CP69) or 64 (CP70) primers showing a variable degree of
complementarity with the EV HPV templates (Berkhout et al, 1995),
and, in our experimental conditions, the concentration of the primers
most homologous to HPV5, HPV8, HPV24, and HPV36 (no to four
mismatches) was 5- or 20-fold lower than that of type-specific primers.
Although it does not demonstrate the actual presence of infectious
viral particles, the detection of EV HPV DNA in the amniotic fluid
prior to rupture of membranes strongly suggests that EV HPV may
cross the placental barrier. Detection of the DNA of the genital
oncogenic HPV types 16 and 18 in the amniotic fluid collected at
different times of pregnancy has also been reported (Armbruster-
Moraes et al, 1994). Furthermore, infection of trophoblasts by genital
HPV has been postulated to account for some spontaneous abortions
(Hermonat et al, 1998).
Hematogenous contamination or ascending infection from the
uterine cervix have been considered to be involved in the transplacental
transmission of genital HPV (Tseng et al, 1992; Armbruster-Moraes
et al, 1994; Puranen et al, 1996, 1997). Hematogenous transmission of
EV HPV seems unlikely because viral sequences were not detected in
peripheral blood mononuclear cells obtained from the patient during
and prior to pregnancy. In contrast, ascending infection seems likely
because unexpectedly the HPV genotypes found in the amniotic fluid
were detected in cervicovaginal scrapes of the patient. These genotypes
and an EV HPV-related genotype (RTRX7) undetected in skin lesions
were also found in oral scrapes of the patient. These data constitute
the first demonstration of EV HPV infection of the squamous epithelium
of mucosa. Interestingly, in an ongoing study, we detected novel
variants of HPV5c and HPV8 in two of 27 cervical scrapes taken from
renal transplant recipients.
Transplacental infection of the child was not directly demonstrated
in our study because no samples were collected at birth; however, it
can be anticipated that such specimens (swabs, nasal aspirates) would
have been contaminated by amniotic fluid. On the other hand, analysis
of specimens taken later after birth would not have allowed to
discriminate between vertical transmission and infection through breast
feeding, nursing, or kissing. Due to the rare occurence of EV, the
vertical transmission of EV HPV is difficult to investigate. An alternative
approach would be to study specimens from pregnant women and
their children born by cesarean section, because EV HPV DNA
sequences have been found in plucked hairs of almost all immuno-
suppressed patients and of about half of immunocompetent subjects
(Boxman et al, 1997). To what extent establishment of a latent HPV
infection may occur in children exposed to oncogenic genital HPV at
birth is still a matter of debate (Cason et al, 1995; Puranen et al, 1996;
Watts et al, 1998); however, it may be assumed that in utero or neonatal
EV HPV infection could lead to the development of cutaneous lesions
in infancy or early childhood in children with an inherited EV-specific
genetic defect (Majewski and Jablonska, 1995). A similar delay (2.5–
10 y) has been reported for the development of benign lesions in skin
autografts performed following skin cancer surgery in EV patients
(Majewski and Jablonska, 1997).
In conclusion, detection of EV HPV in the amniotic fluid, placenta,
and cervicovaginal scrapes of an EV patient renders vertical transmission
of EV HPV likely. It is well known that most children born to
mothers infected with the hepatitis B virus become HBV carriers and
immunologic tolerance is admitted to play a role in the establishment
of these chronic infections (Ahmed et al, 1996). It is tempting
to assume that vertical transmission of EV HPV could induce an
immunotolerance towards infected keratinocytes, which would favor
life-long persistence of EV lesions.
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